Search Results 651-660 of 17033 for monoclonal antibody
antibody levels. So when exposed, they could develop disease ... Some of the mutations are making vaccines, plasma, monoclonal antibodies less effective.
About this study. The purpose of this study is to develop single chain variable fragment antibodies against HLA A2 and test their efficacy in blocking the ...
About this study. The purpose of this study is to determine the safety profile, maximum tolerable dose (MTD) and cohort expansion of single-agent GBR 1342 ...
In response to infection or cancer, immune system cells create a molecule called an antibody. Antibodies latch onto specific cell proteins and signal to the ...
Monoclonal antibody within 4 weeks. Not recovered from toxicity of any prior chemotherapy to grade ≤ 1. History of other active malignancies within 2 years ...
History of clinically significant hypersensitivity associated with monoclonal antibody therapies or components of the emicizumab injection. Eligibility last ...
The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...
... monoclonal antibody. * Arm B: Must have received at least 2 or more lines of therapy, including exposure to a PI, an IMiD, an anti-CD38 monoclonal ...
In this case, though, what the listener is referring to is a combination of two monoclonal antibodies that are given in two different ways. One of them is ...
Monoclonal antibodies, such as alemtuzumab, can bind to and kill malignant lymphocytes. ... The biomarker and antibody results along with your personal ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.